MaxCyte Inc (MXCT)

MaxCyte Inc (MXCT) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $104M; returns 1 day -2.1%, 1 week +7.7%, 1 year -13.6%.

MaxCyte Inc. is a leading cell-engineering focused company that provides enabling platform technologies for the discovery, development, and commercialization of next-generation cell therapeutics. Its core offering is the proprietary ExPERT™ Flow Electroporation® platform, a clinically validated and GMP-compliant non-viral technology.

Groups MXCT belongs to

• Biotechnology
• Life Sciences
• Life Sciences Tools & Services
• Biopharmaceutical
• Healthcare
• Manufacturing
• R&D
• Drug Discovery

MXCT financial model: income statement, cash flow and balance sheet